Professor Geoff Pilkington, study co-author and Head of the Brain
Tumour Research Centre, said: «Although this work is still at an early stage, we have demonstrated key elements that are associated with tumour cell binding to blood vessels and this may provide a target for future drug development to prevent the development of secondary tumours in the
Tumour Research Centre, said: «Although this work is still at an early stage, we have demonstrated key elements that are associated
with tumour cell binding to blood vessels and this may provide a target for future drug development to prevent the development of secondary tumours in the
tumour cell binding to blood vessels and this may provide a target for future drug development to prevent the development of
secondary tumours in the brain.